trifluoromethylpyridine has been researched along with levodopa in 1 studies
| Studies (trifluoromethylpyridine) | Trials (trifluoromethylpyridine) | Recent Studies (post-2010) (trifluoromethylpyridine) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
|---|---|---|---|---|---|
| 13 | 0 | 7 | 17,774 | 1,900 | 4,946 |
| Protein | Taxonomy | trifluoromethylpyridine (IC50) | levodopa (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guertin, PA; Landry, ES | 1 |
1 other study(ies) available for trifluoromethylpyridine and levodopa
| Article | Year |
|---|---|
Differential effects of 5-HT1 and 5-HT2 receptor agonists on hindlimb movements in paraplegic mice.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Disease Models, Animal; Drug Interactions; Exercise Test; Hindlimb; Levodopa; Locomotion; Male; Mice; Movement; Paraplegia; Piperazines; Pyridines; Quipazine; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT2; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Spinal Cord Injuries | 2004 |